Ultragenyx Pharmaceutical is a clinical-stage biopharmaceutical company that develops medicines for rare diseases. According to its disclosure, it lobbied Congress on health-related issues, especially matters tied to drug development and market access. The filings show one disclosure, no reported spending, and that it used the firm Forbes-Tate for lobbying.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BARRETT THORNHILL
The latest disclosures for this client.
FORBES-TATE
Q1FORBES-TATE
RAThe entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
FORBES-TATE